Showing results (111-120 of 905) with videos related to

Sort By:
Pageof 91
International Journal of Cardiology|December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANTSally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
European Heart Journal|October 24, 2018
Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort studyGianluigi Savarese, Ulf Dahlström, Peter Vasko, et al.
Clinical Cardiology|September 5, 2019
Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trialJoão Pedro Ferreira, Xavier Rossello, Bertram Pitt, et al.
The American Journal of Cardiology|February 28, 2002
Effect of losartan in aging-related endothelial impairmentSanjay Rajagopalan, Robert Brook, Rajendra H Mehta, et al.
Circulation|October 1, 2008
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)Bertram Pitt, George Bakris, Luis M Ruilope, et al.
International Journal of Cardiology|February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
JAMA Cardiology|August 25, 2018
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical TrialPeder Langeland Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure|November 30, 2019
Influence of Age on Efficacy and Safety of Spironolactone in Heart FailureOrly Vardeny, Brian Claggett, Muthiah Vaduganathan, et al.
Circulation. Heart Failure|December 21, 2018
Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection FractionPeder L Myhre, Eileen O'Meara, Brian L Claggett, et al.
Circulation|November 23, 2006
Variable impact of combining fatal and nonfatal end points in heart failure trialsHicham Skali, Marc A Pfeffer, Jacobus Lubsen, et al.
Pageof 91